Medical condition
Respiratory Syncytial Virus
Respiratory Syncytial Virus is a medical condition tracked by NovaPharmaNews across 6 associated drugs and ongoing industry coverage. Explore approved and pipeline therapies, regulatory status, and the latest developments.
Associated drugs & therapies
- respiratory syncytial virus mrna vaccine (MRESVIA) Antiinfectives for systemic use (J07)
- palivizumab (SYNAGIS) Antiinfectives for systemic use (J06)
- clesrovimab (ENFLONSIA) Antiinfectives for systemic use (J06)
- nirsevimab (BEYFORTUS) Antiinfectives for systemic use (J06)
- recombinant respiratory syncytial virus pre-fusion f protein, adjuvanted with as01e (AREXVY) Antiinfectives for systemic use (J07)
- respiratory syncytial virus vaccine (bivalent, recombinant) (ABRYSVO) Antiinfectives for systemic use (J07)